124 related articles for article (PubMed ID: 10913818)
1. Novel compounds, '1,3-selenazine derivatives' as specific inhibitors of eukaryotic elongation factor-2 kinase.
Cho SI; Koketsu M; Ishihara H; Matsushita M; Nairn AC; Fukazawa H; Uehara Y
Biochim Biophys Acta; 2000 Jul; 1475(3):207-15. PubMed ID: 10913818
[TBL] [Abstract][Full Text] [Related]
2. Novel compounds, 1,3-selenazine derivatives, as antibacterial agents against Escherichia coli and Staphylococcus aureus.
Koketsu M; Ishihara H; Hatsu M
Res Commun Mol Pathol Pharmacol; 1998 Aug; 101(2):179-86. PubMed ID: 9821214
[TBL] [Abstract][Full Text] [Related]
3. Elongation factor-2 kinase: effective inhibition by the novel protein kinase inhibitor rottlerin and relative insensitivity towards staurosporine.
Gschwendt M; Kittstein W; Marks F
FEBS Lett; 1994 Jan; 338(1):85-8. PubMed ID: 8307162
[TBL] [Abstract][Full Text] [Related]
4. Regulation of elongation factor-2 kinase by pH.
Dorovkov MV; Pavur KS; Petrov AN; Ryazanov AG
Biochemistry; 2002 Nov; 41(45):13444-50. PubMed ID: 12416990
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylation of elongation factor-2 kinase on serine 499 by cAMP-dependent protein kinase induces Ca2+/calmodulin-independent activity.
Diggle TA; Subkhankulova T; Lilley KS; Shikotra N; Willis AE; Redpath NT
Biochem J; 2001 Feb; 353(Pt 3):621-6. PubMed ID: 11171059
[TBL] [Abstract][Full Text] [Related]
6. Regulation of protein-synthesis elongation-factor-2 kinase by cAMP in adipocytes.
Diggle TA; Redpath NT; Heesom KJ; Denton RM
Biochem J; 1998 Dec; 336 ( Pt 3)(Pt 3):525-9. PubMed ID: 9841860
[TBL] [Abstract][Full Text] [Related]
7. Elongation factor-2 kinase regulates TG2/β1 integrin/Src/uPAR pathway and epithelial-mesenchymal transition mediating pancreatic cancer cells invasion.
Ashour AA; Gurbuz N; Alpay SN; Abdel-Aziz AA; Mansour AM; Huo L; Ozpolat B
J Cell Mol Med; 2014 Nov; 18(11):2235-51. PubMed ID: 25215932
[TBL] [Abstract][Full Text] [Related]
8. Signal Integration at Elongation Factor 2 Kinase: THE ROLES OF CALCIUM, CALMODULIN, AND SER-500 PHOSPHORYLATION.
Tavares CDJ; Giles DH; Stancu G; Chitjian CA; Ferguson SB; Wellmann RM; Kaoud TS; Ghose R; Dalby KN
J Biol Chem; 2017 Feb; 292(5):2032-2045. PubMed ID: 27956550
[TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of an inhibitor of eukaryotic elongation factor 2 kinase against human cancer cell lines.
Arora S; Yang JM; Kinzy TG; Utsumi R; Okamoto T; Kitayama T; Ortiz PA; Hait WN
Cancer Res; 2003 Oct; 63(20):6894-9. PubMed ID: 14583488
[TBL] [Abstract][Full Text] [Related]
10. Detection of anti-elongation factor 2 kinase (calmodulin-dependent protein kinase III) antibodies in patients with systemic lupus erythematosus.
Arora S; Yang JM; Craft J; Hait W
Biochem Biophys Res Commun; 2002 May; 293(3):1073-6. PubMed ID: 12051769
[TBL] [Abstract][Full Text] [Related]
11. Structure of the complex between calmodulin and a functional construct of eukaryotic elongation factor 2 kinase bound to an ATP-competitive inhibitor.
Piserchio A; Isiorho EA; Dalby KN; Ghose R
J Biol Chem; 2023 Jun; 299(6):104813. PubMed ID: 37172726
[TBL] [Abstract][Full Text] [Related]
12. Targeting elongation factor-2 kinase (eEF-2K) induces apoptosis in human pancreatic cancer cells.
Ashour AA; Abdel-Aziz AA; Mansour AM; Alpay SN; Huo L; Ozpolat B
Apoptosis; 2014 Jan; 19(1):241-58. PubMed ID: 24193916
[TBL] [Abstract][Full Text] [Related]
13. The molecular mechanism of eukaryotic elongation factor 2 kinase activation.
Tavares CD; Ferguson SB; Giles DH; Wang Q; Wellmann RM; O'Brien JP; Warthaka M; Brodbelt JS; Ren P; Dalby KN
J Biol Chem; 2014 Aug; 289(34):23901-16. PubMed ID: 25012662
[TBL] [Abstract][Full Text] [Related]
14. What is the impact of eukaryotic elongation factor 2 kinase on cancer: A systematic review.
Li S; Li Y; Bai Y
Eur J Pharmacol; 2019 Aug; 857():172470. PubMed ID: 31226250
[TBL] [Abstract][Full Text] [Related]
15. ADP enhances the allosteric activation of eukaryotic elongation factor 2 kinase by calmodulin.
Piserchio A; Long KJ; Browning LS; Bohanon AL; Isiorho EA; Dalby KN; Ghose R
Proc Natl Acad Sci U S A; 2023 Apr; 120(17):e2300902120. PubMed ID: 37068230
[TBL] [Abstract][Full Text] [Related]
16. 1,3-Selenazine derivatives induce cytotoxicity and DNA fragmentation in human HT-1080 fibrosarcoma cells.
Koketsu M; Ishihara H; Wu W; Murakami K; Saiki I
Eur J Pharm Sci; 1999 Dec; 9(2):157-61. PubMed ID: 10620728
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the domain structure of elongation factor-2 kinase by mutagenesis.
Diggle TA; Seehra CK; Hase S; Redpath NT
FEBS Lett; 1999 Aug; 457(2):189-92. PubMed ID: 10471776
[TBL] [Abstract][Full Text] [Related]
18. Elongation factor-2 kinase (eEF-2K) expression is associated with poor patient survival and promotes proliferation, invasion and tumor growth of lung cancer.
Bircan HA; Gurbuz N; Pataer A; Caner A; Kahraman N; Bayraktar E; Bayraktar R; Erdogan MA; Kabil N; Ozpolat B
Lung Cancer; 2018 Oct; 124():31-39. PubMed ID: 30268477
[TBL] [Abstract][Full Text] [Related]
19. Cloning and expression of cDNA encoding protein synthesis elongation factor-2 kinase.
Redpath NT; Price NT; Proud CG
J Biol Chem; 1996 Jul; 271(29):17547-54. PubMed ID: 8663182
[TBL] [Abstract][Full Text] [Related]
20. Investigating the kinetic mechanism of inhibition of elongation factor 2 kinase by NH125: evidence of a common in vitro artifact.
Devkota AK; Tavares CD; Warthaka M; Abramczyk O; Marshall KD; Kaoud TS; Gorgulu K; Ozpolat B; Dalby KN
Biochemistry; 2012 Mar; 51(10):2100-12. PubMed ID: 22352903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
